Correlation Between RenovoRx and Lineage Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Lineage Cell Therapeutics, you can compare the effects of market volatilities on RenovoRx and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Lineage Cell.

Diversification Opportunities for RenovoRx and Lineage Cell

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between RenovoRx and Lineage is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and Lineage Cell go up and down completely randomly.

Pair Corralation between RenovoRx and Lineage Cell

Given the investment horizon of 90 days RenovoRx is expected to generate 1.54 times more return on investment than Lineage Cell. However, RenovoRx is 1.54 times more volatile than Lineage Cell Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  277.00  in RenovoRx on August 29, 2024 and sell it today you would lose (141.00) from holding RenovoRx or give up 50.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Lineage Cell Therapeutics

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

RenovoRx and Lineage Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Lineage Cell

The main advantage of trading using opposite RenovoRx and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.
The idea behind RenovoRx and Lineage Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments